Biomedicines | Free Full-Text | Activation of MAP Kinase Pathway by Polyisoprenylated Cysteinyl…
Figure 1.
NSL-YHJ-2-27 suppresses the viability of breast cancer cells. After treatment of cells with the indicated concentrations of NSL-YHJ-2-27 (0, 0.5, 1, 2, 5, 10, 20, and 50 µM), resazurin reduction assay was performed to…